Response to letter: 'Acute heart failure, type 2 diabetes and loop diuretic use: any adjunct role for SGLT-2 inhibitors?'

被引：0
|
作者：
Cunha, Filipe M. [1 ]
Bettencourt, Paulo [2 ,3 ]
Lourenco, Patricia [3 ,4 ,5 ]
机构：
[1] Ctr Hosp Tamega & Sousa, Dept Endocrinol, Ave Hosp Padre Amer 210, P-4564007 Guilhufe, Penafiel, Portugal
[2] Hosp CUF Porto, Dept Internal Med, Porto, Portugal
[3] Univ Porto, Fac Med, Porto, Portugal
[4] Ctr Hosp & Univ Sao Joao, Dept Internal Med, Porto, Portugal
[5] Ctr Hosp & Univ Sao Joao, Dept Internal Med, Heart Failure Clin, Porto, Portugal
来源：
JOURNAL OF CARDIOVASCULAR MEDICINE | 2020年 / 21卷 / 04期
关键词：
D O I：
10.2459/JCM.0000000000000947
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：344 / 344
页数：1
相关论文
共 50 条
  • [41] Comment on SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice
    Dogar, Mata-e-Alla
    Azeem, Bazil
    Asim, Rabia
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 390
  • [42] The role of SGLT-2 inhibitors in managing type 2 diabetes (vol 88, pg 47, 2021)
    Tsushima, Y.
    Lansang, M. C.
    Makin, V.
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2021, 88 (04) : 205 - 205
  • [43] SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection
    Androutsakos, Theodoros
    Nasiri-Ansari, Narjes
    Bakasis, Athanasios-Dimitrios
    Kyrou, Ioannis
    Efstathopoulos, Efstathios
    Randeva, Harpal S.
    Kassi, Eva
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [44] SGLT-2 inhibitors as adjunctive to insulin therapy in type 1 diabetes
    Maj-Podsiadlo, Anna
    Cichocka, Edyta
    Gumprecht, Janusz
    [J]. CLINICAL DIABETOLOGY, 2020, 9 (03): : 189 - 192
  • [45] TYPE 1 DIABETES: IMPACT OF SGLT-2 INHIBITORS ON GLYCEMIC CONTROL
    Lavrador, M.
    Araujo, B.
    Araujo, C.
    Melo, M.
    Baptista, C.
    Barros, L.
    Paiva, I.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A181 - A181
  • [46] Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors
    Dabrowski, Mariusz
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 18
  • [47] SGLT2 inhibitors in hypertension: Role beyond diabetes and heart failure
    Gupta, Rahul
    Maitz, Theresa
    Egeler, David
    Mehta, Anila
    Nyaeme, Mark
    Hajra, Adrija
    Goel, Akshay
    Sreenivasan, Jayakumar
    Patel, Neel
    Aronow, Wilbert S.
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2023, 33 (08) : 479 - 486
  • [48] Role of SGLT2 Inhibitors in Patients with Diabetes Mellitus and Heart Failure
    Verbrugge F.H.
    [J]. Current Heart Failure Reports, 2017, 14 (4) : 275 - 283
  • [49] HEART FAILURE, DIABETES AND USE OF SGLT2 INHIBITORS - A MISSED OPPORTUNITY
    Coomer, Soham
    Jain, Shruti
    Tun, Thet
    Kumar, Somnath
    [J]. HEART, 2020, 106 : A79 - A80
  • [50] SGLT2i and loop diuretic withdrawal or downtitration in heart failure
    Domingo, Mar
    Ruiz-Cueto, Maria
    Teis, Albert
    Lupon, Josep
    Alonso, Nuria
    Bayes-Genis, Antoni
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2023, 76 (11): : 943 - 945
12345